To treat RA, leflunomide is a key DMARD, which is a pyrimidine inhibitor that inhibits the dihydroorotate dehydrogenase (DHODH) enzyme to prevent joint inflammation. The gene discussed is DHODH; the disease is rheumatoid arthritis.